Status:
COMPLETED
ICP Versus Intracranial Compliance Guided Management in SAH
Lead Sponsor:
Oslo University Hospital
Conditions:
Subarachnoid Hemorrhage (SAH)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.
Detailed Description
In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subarachnoid hemorrhage, acute
- Intracerebral pressure monitoring device inserted
- Exclusion criteria:
- No intracranial pressure monitoring
- Age \< 18 years
Exclusion
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00248690
Start Date
November 1 2005
End Date
June 1 2009
Last Update
January 19 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet University Hospital
Oslo, Norway, 0027